ANDEMBRY sol inj 200 mg 1 pce
7680695530018
CH-69553
B06AC07
02.99.0.
1 / 3
google
Details
- Product number
- 6955301
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigpen
- Composition
- garadacimabum 200 mg, histidinum, arginini hydrochloridum, prolinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml.
Articles (1)
Andembry 200 mg, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16158.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2025
Authorization holder
CSL Behring AG
3014 Bern
Authorization information
- Swissmedic authorization number
- 69553
- Drug name
- Andembry, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B06AC07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/02/2025
- Authorization expiration date
- 23/02/2030
- IT number
- 02.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANDEMBRY sol inj 200 mg 1 pce
- Description (DE)
- ANDEMBRY Inj Lös 200 mg 1 Stk
- Market launch
- 01/07/2025
- Market withdrawal
- 01/01/2040
- Narcotic (BTM)
- No